课题基金 / 基金详情

Nirmatrelvir/ritonavir (Paxlovid) in the prevention of long-term cardiovascular outcomes: The paxloviD Effectiveness For the prEvention of loNg coviD (DEFEND) clinical trial.

Nirmatrelvir/ritonavir (Paxlovid) in the prevention of long-term cardiovascular outcomes: The paxloviD Effectiveness For the prEvention of loNg coviD (DEFEND) clinical trial.
Nirmatrelvir/ritonavir (Paxlovid) 预防长期心血管结局:paxlovid 对于预防长期新冠病毒 (DEFEND) 的有效性临床试验。
批准号:
494291
负责人:
Quinn Kieran L
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-09-01 至 2024-09-01

项目摘要

项目成果

Quinn Kieran L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The paxloviD Effectiveness For the prEvention of LoNg coviD (DEFEND) clinical trial will look to see if giving Paxlovid to people when they are first sick in hospital with COVID will lead to fewer deaths, heart problems, strokes, diabetes, or blood clots
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the landscape of palliative care needs of people with heart failure in Ontario to improve future care delivery
  • 批准号:
    472684
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Quinn Kieran L
  • 依托单位:
Developing evidence-informed, regionally contextualized policy options to increase access and use of palliative care for people with heart failure in Ontario
  • 批准号:
    475244
  • 项目类别:
    Operating Grants
  • 资助金额:
    $10.91万
  • 财政年份:
    2022
  • 负责人:
    Quinn Kieran L
  • 依托单位:
Identifying Service Gaps in Virtual Palliative Care to Inform Health Policy Across Canada
  • 批准号:
    447359
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Quinn Kieran L
  • 依托单位:
Identifying Disparities in Equitable Access to Virtual Palliative Care
  • 批准号:
    447269
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Quinn Kieran L
  • 依托单位:
国内基金
海外基金
基于Relm-β核转位激活EndMT促进肺动脉高压研究肺心汤预防 Long COVID 机制
维生素D调控巨噬细胞极化在改善“Long COVID”中作用和机制的分子流行病学研究